{{Rsnum
|rsid=6556756
|Gene=LOC100507193
|Chromosome=5
|position=164462274
|Orientation=plus
|GMAF=0.1749
|Gene_s=LARP4
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 1.8 | 15.9 | 82.3
| HCB | 17.5 | 50.4 | 32.1
| JPT | 23.0 | 59.3 | 17.7
| YRI | 0.0 | 8.8 | 91.2
| ASW | 0.0 | 7.0 | 93.0
| CHB | 17.5 | 50.4 | 32.1
| CHD | 25.9 | 46.3 | 27.8
| GIH | 5.0 | 28.7 | 66.3
| LWK | 0.9 | 3.6 | 95.5
| MEX | 1.7 | 20.7 | 77.6
| MKK | 1.9 | 20.5 | 77.6
| TSI | 0.0 | 6.9 | 93.1
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs6556756
|PubMedID=17903305
|Condition=Breast cancer
|Gene=Intergenic
|Risk Allele=
|pValue=5.00E-007
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs6556756
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:17903305; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study (Initial Sample Size: 1,345 individuals (Framingham); Replication Sample Size: NR). This variant is associated with Breast cancer.
|Drugs=
|Drug Classes=
|Diseases=Breast Neoplasms
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356382
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs6556756
|overall_frequency_n=115
|overall_frequency_d=126
|overall_frequency=0.912698
|n_genomes=52
|n_genomes_annotated=0
|n_haplomes=97
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}